{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:34:16Z","timestamp":1707525256147},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,18]]},"DOI":"10.7759\/cureus.43711","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T19:25:39Z","timestamp":1692386739000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Structure and Function in Patients With Obesity and Non-alcoholic Fatty Liver Disease"],"prefix":"10.7759","author":[{"given":"Zemfira","family":"Asatullina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albina V","family":"Sineglazova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani N","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al.. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018, 67:328-57. 10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi Z","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, et al.. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019, 69:2672-82. 10.1002\/hep.30251","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0010-0","article-title":"Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease","volume":"15","author":"Anstee QM","year":"2018","unstructured":"Anstee QM, Mantovani A, Tilg H, Targher G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2018, 15:425-39. 10.1038\/s41575-018-0010-0","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014279","article-title":"Longitudinal association of non-alcoholic fatty liver disease with changes in myocardial structure and function: the CARDIA study","volume":"9","author":"VanWagner LB","year":"2020","unstructured":"VanWagner LB, Wilcox JE, Ning H, et al.. Longitudinal association of non-alcoholic fatty liver disease with changes in myocardial structure and function: the CARDIA study. J Am Heart Assoc. 2020, 9:e014279. 10.1161\/JAHA.119.014279","journal-title":"J Am Heart Assoc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12865\/CHSJ.47.02.19","article-title":"Contribution of modern echocardiographic techniques in the detection of subclinical heart dysfunction in young adults with non-alcoholic fatty liver disease","volume":"47","author":"Moise CG","year":"2021","unstructured":"Moise CG, Donoiu I, T\u00e2rtea GC, Mirea O, Rogoveanu I. Contribution of modern echocardiographic techniques in the detection of subclinical heart dysfunction in young adults with non-alcoholic fatty liver disease. Curr Health Sci J. 2021, 47:275-83. 10.12865\/CHSJ.47.02.19","journal-title":"Curr Health Sci J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02070-0","article-title":"Association between nonalcoholic fatty liver disease and cardiac function and structure-a meta-analysis","volume":"66","author":"Borges-Canha M","year":"2019","unstructured":"Borges-Canha M, Neves JS, Lib\u00e2nio D, et al.. Association between nonalcoholic fatty liver disease and cardiac function and structure-a meta-analysis. Endocrine. 2019, 66:467-76. 10.1007\/s12020-019-02070-0","journal-title":"Endocrine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort","volume":"71","author":"Simon TG","year":"2022","unstructured":"Simon TG, Roelstraete B, Hagstr\u00f6m H, Sundstr\u00f6m J, Ludvigsson JF. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut. 2022, 71:1867-75. 10.1136\/gutjnl-2021-325724","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107 E","year":"2021","unstructured":"Muzurovi\u0107 E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 2021, 119:154770. 10.1016\/j.metabol.2021.154770","journal-title":"Metabolism"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl EP","year":"2019","unstructured":"Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS. Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review. J Am Coll Cardiol. 2019, 73:948-63. 10.1016\/j.jacc.2018.11.050","journal-title":"J Am Coll Cardiol"},{"key":"ref10","unstructured":"Body mass index - BMI. (2010). Accessed. January 20, 2023: http:\/\/www.euro.who.int\/en\/health- topics\/disease-prevention\/nutrition\/a-healthy-lifestyle\/body-mass-index-bmi."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwab154","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"29","author":"Visseren FL","year":"2022","unstructured":"Visseren FL, Mach F, Smulders YM, et al.. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2022, 29:5-115. 10.1093\/eurjpc\/zwab154","journal-title":"Eur J Prev Cardiol"},{"key":"ref12","unstructured":"Tanita. Instruction manual for InnerScan V segmental body composition monitor, BC-601. (2023). Accessed. May 25, 2023: https:\/\/www.manualslib.com\/manual\/2723866\/Tanita- Innerscan-V-Bc-601.html."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams B","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al.. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018, 39:3021-104. 10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jew041","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Lang RM","year":"2016","unstructured":"Lang RM, Luigi BP, Mor-Avi V, et al.. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016, 17:412. 10.1093\/ehjci\/jew041","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al.. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023, 77:1797-835. 10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.20969\/VSKM.2021.14(1).41-46","article-title":"Risk factor profile of chronic non-communicable diseases in different obesity phenotypes. (Article in Russian)","volume":"41","author":"Nurieva AR","year":"2021","unstructured":"Nurieva AR, Sineglazova AV, Kim TY, Parve S. Risk factor profile of chronic non-communicable diseases in different obesity phenotypes. (Article in Russian). Bull Contemp Clin Med. 2021, 41:6. 10.20969\/VSKM.2021.14(1).41-46","journal-title":"Bull Contemp Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020298","article-title":"Homeostasis of glucose and lipid in non-alcoholic fatty liver disease","volume":"20","author":"Chao HW","year":"2019","unstructured":"Chao HW, Chao SW, Lin H, Ku HC, Cheng CF. Homeostasis of glucose and lipid in non-alcoholic fatty liver disease. Int J Mol Sci. 2019, 20:298. 10.3390\/ijms20020298","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318093","article-title":"Obesity, adipose tissue and vascular dysfunction","volume":"128","author":"Koenen M","year":"2021","unstructured":"Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021, 128:951-68. 10.1161\/CIRCRESAHA.121.318093","journal-title":"Circ Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.742178","article-title":"Inflammation in metabolic cardiomyopathy","volume":"8","author":"Wenzl FA","year":"2021","unstructured":"Wenzl FA, Ambrosini S, Mohammed SA, Kraler S, L\u00fcscher TF, Costantino S, Paneni F. Inflammation in metabolic cardiomyopathy. Front Cardiovasc Med. 2021, 8:742178. 10.3389\/fcvm.2021.742178","journal-title":"Front Cardiovasc Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.053","article-title":"Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"61","author":"Shah RV","year":"2013","unstructured":"Shah RV, Abbasi SA, Heydari B, et al.. Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013, 61:1698-706. 10.1016\/j.jacc.2013.01.053","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2021.07.010","article-title":"Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction","volume":"6","author":"Salah HM","year":"2021","unstructured":"Salah HM, Pandey A, Soloveva A, et al.. Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction. JACC Basic Transl Sci. 2021, 6:918-32. 10.1016\/j.jacbts.2021.07.010","journal-title":"JACC Basic Transl Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.11.007","article-title":"Risk of heart failure in patients with nonalcoholic fatty liver disease: JACC\u00a0review\u00a0topic\u00a0of\u00a0the\u00a0week","volume":"79","author":"Mantovani A","year":"2022","unstructured":"Mantovani A, Byrne CD, Benfari G, Bonapace S, Simon TG, Targher G. Risk of heart failure in patients with nonalcoholic fatty liver disease: JACC\u00a0review\u00a0topic\u00a0of\u00a0the\u00a0week. J Am Coll Cardiol. 2022, 79:180-91. 10.1016\/j.jacc.2021.11.007","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13222","article-title":"Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues","volume":"8","author":"Itier R","year":"2021","unstructured":"Itier R, Guillaume M, Ricci JE, et al.. Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues. ESC Heart Fail. 2021, 8:789-98. 10.1002\/ehf2.13222","journal-title":"ESC Heart Fail"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01725-z","article-title":"The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study","volume":"21","author":"Park J","year":"2022","unstructured":"Park J, Kim G, Kim H, Lee J, Jin SM, Kim JH. The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study. Cardiovasc Diabetol. 2022, 21:287. 10.1186\/s12933-022-01725-z","journal-title":"Cardiovasc Diabetol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.22092\/ARI.2021.356231.1808","article-title":"Meta-analysis of non-alcoholic fatty liver disease and electromechanical reconstruction of myocardium","volume":"77","author":"Tretyakova VA","year":"2022","unstructured":"Tretyakova VA, Zhernakova NI, Arisheva OS, Garmash IV, Tretyakov A, Gerasimov NI, Ermilov OV. Meta-analysis of non-alcoholic fatty liver disease and electromechanical reconstruction of myocardium. Arch Razi Inst. 2022, 77:135-40. 10.22092\/ARI.2021.356231.1808","journal-title":"Arch Razi Inst"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study","volume":"62","author":"VanWagner LB","year":"2015","unstructured":"VanWagner LB, Wilcox JE, Colangelo LA, et al.. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology. 2015, 62:773-83. 10.1002\/hep.27869","journal-title":"Hepatology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014609","article-title":"Echocardiographic imaging challenges in obesity: guideline recommendations and limitations of adjusting to body size","volume":"9","author":"Singh M","year":"2020","unstructured":"Singh M, Sethi A, Mishra AK, Subrayappa NK, Stapleton DD, Pellikka PA. Echocardiographic imaging challenges in obesity: guideline recommendations and limitations of adjusting to body size. J Am Heart Assoc. 2020, 9:e014609. 10.1161\/JAHA.119.014609","journal-title":"J Am Heart Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/178330-cardiac-structure-and-function-in-patients-with-obesity-and-non-alcoholic-fatty-liver-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:28Z","timestamp":1707509068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/178330-cardiac-structure-and-function-in-patients-with-obesity-and-non-alcoholic-fatty-liver-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.43711","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,18]]}}}